Protein kinase I of Mycobacterium tuberculosis: cellular localization and expression during infection of

Anubha Singh1, Yogendra Singh, Richard Pine

  • 1Public Health Research Institute, 225 Warren Street, Newark, NJ 07103, USA.

Insights

Mycobacterium tuberculosis protein kinase I (PknI) exhibits autophosphorylation and transphosphorylation activity, localizing to the cytosol. Its expression decreases during macrophage infection, distinguishing it from membrane-bound PknA.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Mycobacterium tuberculosis possesses numerous protein kinases, including PknA and PknB, which are crucial for its survival.
  • The specific roles and localization of other protein kinases, such as PknI, remain less understood.
  • PknI has a unique amino acid composition in its catalytic loop.

Purpose of the Study:

  • To characterize the biochemical activity and sub-cellular localization of Protein kinase I (PknI) from Mycobacterium tuberculosis.
  • To investigate the expression pattern of PknI during host-pathogen interaction within human macrophages.
  • To differentiate PknI from other well-studied M. tuberculosis protein kinases like PknA and PknB.

Main Methods:

  • Autophosphorylation and transphosphorylation assays were performed to determine PknI's enzymatic activity.
  • Immunoblot analysis using anti-PknI antibodies was employed to ascertain its sub-cellular localization.
  • Quantitative reverse transcription PCR (RT-PCR) combined with molecular beacons was used to measure pknI gene expression.

Main Results:

  • PknI demonstrated both autophosphorylation and transphosphorylation capabilities.
  • Immunoblotting confirmed PknI's localization within the bacterial cytosol, contrasting with the membrane-bound PknA.
  • Relative pknI expression significantly decreased during the infection of THP-1 human macrophages, while pknA and pknB expression increased.

Conclusions:

  • PknI is a functionally active protein kinase in Mycobacterium tuberculosis, distinct from PknA and PknB.
  • PknI's cytosolic localization and its differential expression during macrophage infection suggest a unique role in the pathogen's lifecycle.
  • These findings highlight PknI as a potential target for novel anti-tubercular therapies.

Related Concept Videos

Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...